Moore Capital Management, LP Abb Vie Inc. Transaction History

Moore Capital Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $8.02 Million - $9.28 Million	60,000 New	60,000 $8.94 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $18.7 Million - $23.2 Million	-141,739 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $15.2 Million - $19.3 Million	141,739 New	141,739 $19.2 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.